Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Kno2

Explore full profile

Enables connectivity to millions of healthcare providers and the capability to send, receive, find, and use patient information with everyone

Boise, United StatesFounded 2009Health Tech & Medtech
Valuation $50–100M Last recorded · 2021
Revenue $1–10M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Kno2 and the history behind them.

About Kno2

Kno2 operates as a central player in the healthcare communication sector, aiming to address the persistent issue of interoperability. Founded in 2010 by Jon Elwell, the company has established a communication API that facilitates the secure and efficient exchange of patient information. This network connects a wide array of stakeholders, including patients, healthcare providers, payers, and various IT vendors. Jon Elwell, who also served as the initial CEO, brought leadership experience from his prior role as CEO of ScripPoint.

The core of Kno2's business is its network, which unifies disparate systems and communication standards like Direct Secure Messaging and digital faxing. Instead of building multiple individual connections, organizations can link to the Kno2 Communication API once to gain access to a broad network of electronic health record systems (EHRs), healthcare organizations, and other technologies. This model simplifies the process of sharing critical patient data, which has historically been a fragmented and cumbersome process. The company's platform is designed to handle a large volume of transactions, having processed over 1.2 billion healthcare transactions and connected more than 3 million providers.

Kno2 generates revenue through a subscription-based model, offering different tiers of service to its clients, which range from small provider practices to large health systems and technology partners. The platform's value proposition lies in its ability to streamline workflows, reduce administrative burdens associated with manual data exchange, and ultimately improve patient care by ensuring that timely and accurate information is available at the point of care. By connecting to major interoperability frameworks, Kno2 positions itself as a comprehensive solution for healthcare data exchange.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2009
Headquarters
Boise, United States
Employees
55
Open positions
None listed
Dealroom signal
65.7/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Tech for Hospitals and Clinics, Hard Tech
Business model
SaaS
Client focus
b2c

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Jul 2021 $15M $60M Providence Ventures · Health Enterprise Partners —
DEBT✓Debt Jun 2014 $1.8M — Undisclosed —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022
2021
2020 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Kno2 website traffic

Latest recorded traffic for Kno2 is 5.9K monthly website visits, down 6.3% over the last three months. Kno2's team declined 1.8% over the past year.

Latest monthly visits5.9K 3-month web change-6.3% 1-year team growth-1.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Providence Ventures
  • Health Enterprise Partners

Other known investors1 additional known investor

  • First Analysis
Team profiled 14 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Kno2 on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Kno2’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.